Italian Society of Nephrology  by unknown
Immunocytochemical and ultrastructural study of renal interstitial
fibrosis. A. Vangelista, G. Frascâ, G. Biagini, G. Cenacchi, B. Seven,
G. P. Colonna, and V. Bonomini. Institute of Nephrology and Institute
of Electron Microscopy, St. Orsola University Hospital, Bologna, Italy.
Interstitial fibrosis may frequently occur in renal pathology and play a
role in the progression of various nephropathies. However, the mecha-
nisms of fibrosis, and particularly the relationship between stromal cells
and the extracellular matrix are not yet well defined. This point was
investigated in 16 renal biopsy specimens with interstitial fibrosis at
various degrees by evaluating the presence of myofibroblasts (electron
microscopy), fibronectin, and type IV collagen (indirect immunofluo-
rescence and immuno-peroxidase with specific rabbit antisera). Myofi-
broblasts, stromal cells sharing both fibroblast and muscle cell features,
were rarely observed in biopsy specimens without interstitial lesions,
while increased in the presence of fibrosis. Fibronectin, a glycoprotein
which represents a major connective tissue protein, was normally
present in the interstitium and progressively increased along with the
extent of fibrosis. In eight biopsy specimens it was found closely related
to the tubular basement membranes (TBM): This finding correlated
with the TBM thickening observed at light microscopy. Type IV
collagen, the main collagenous component of basement membranes,
was found in the interstitium only in biopsy specimens where interstitial
fibrosis was evident. A correlation was observed between the presence
of type IV collagen in the interstitium and the number of myofibroblasts
at electron microscopy.
A hitherto unrecognized pattern of passive Heymann nephritis (PHN)
defined by amonoclonal antibody (Mab) directed against brush border
(BB). L. Allegri, P. Ronco, C. Melcion, E. Pirotsky, and P. Verroust.
Institut National de Ia Sante et de la Recherche Medicale Unites 64 and
200, Paris and Clamart, France. PHN is a model of membranous
glomerulonephritis induced in the rat by injection of heterologous
antibodies against BB antigens. It is generally felt that deposits are
formed "in situ" by the binding of circulating antibodies to antigen(s)
already present within the glomerular capillary wall (GCW). We report
here the induction of transient extramembranous deposits using a Mab
which, by indirect immunofluorescence (IF) on frozen kidney sections,
reacts with an antigen present both within the BB and GCW. This
antibody, an IgG 2a, with a p1 of 6.5 is directed against a 90,000—
molecular weight polypeptide, with an approximate p1 of 6, which can
be identified by immunoprecipitation of radiolabelled BB and glomeru-
lar antigens. Reactive antigenic sites are not restricted to the kidney and
can be identified within the BB of the gut, the bile canaliculi of the liver,
and the small vessels of lung, heart, spleen, and liver. Antigen is also
detected in the blood stream. Perfusion of isolated rat kidney demon-
strated binding on GCW and on the base of proximal tubular cells. In
vivo localization was studied by indirect IF 1 hr to 15 days after an
intravenous injection of 2 mg of Mab. Binding on GCW was detectable
by IF a few minutes after the injection, maximum at 4 hr, and decreased
progressively. BB binding initially present I to 4 days after IV de-
creased progressively as deposits became clearly detectable at the base
of proximal tubular cells. Clear-cut deposits were detectable in liver,
lung, spleen, and heart. Quantitative measurements using radiolabelled
antibody fully confirmed immunofluorescence observations. These
experiments, using a Mab, identify a new pattern of PHN characterized
by transient extra membranous deposits potentially formed in situ. The
kinetics described here, hitherto undescribed in this system, may be
related to the simultaneous presence of circulating antigen. The intrare-
nal distribution of antibody in vivo suggests that its membrane binding
properties may influence its transglomerular and transtubular transfer.
Infection-induced stones and pyelonephritis prevented by reducing
urinary phosphorus in rats. G. Barsotti, C. Cristofano, A. Macaluso, G.
Calabrese, G. Vagelli, I. Vlamis, R. Baldi, and S. Giovannetti, 1
Clinica Medica Generate e Terapia, Universitd di Pisa, Pisa, Italy.
Urinary infection was induced in 77 adult male Wistar rats by introduc-
ing, in the bladder, a stainless steel tube containing a culture of Proteus
mirabilis. The rats were randomly divided into three groups: group I,
(control) 30 rats maintained, during the period of study, on a standard
diet (inorganic phosphorus content (Pi) = 980 mg/I0O g); group 2, 21
rats fed with a low-phosphorus diet (Pi = 100 mg/lO0 g); group 3, 26 rats
fed with a standard diet supplemented with colloidal Al(OH)3 (1200 mg/
100 g of food). Six rats of each group were put in metabolic cages to
evaluate the urinary excretion of Pi. Pi concentration was 268.0 95.9
mg% in group 1, 22.6 15.4 mg% in group 2, and 36.8 17.0 mg% in
group 3. After 15 days the surviving animals were killed and necroscopy
was performed. Some rats died with renal failure before the end of the
period of study: group 1, 16 rats (53.3%); group 2, 4 rats (19%); and
group 3, 9 rats (34.6%). Pyelonephritis occurred in 26 rats of group I
(86%); in 8 of group 2(38%); and in 16 of group 3 (6 1%). Seventeen rats
of group 1 (56%), 3 of group 2 (14%), and 10 of group 3 (38%) had
cortical and medullary abscesses. Papillary necrosis was present in 12
rats of group 1(40%), in I of group 2(5%), and in 4 of group 3 (15%).
Struvite formation was 36.9 mg/rat in group 1, 8.3 mg/rat in group 2, (P
<0.001) and 3.5 mg/rat in group 3 (P < 0.001). This study demonstrates
that a decrease of the urinary Pi excretion obtained by a low phospho-
rous diet or by colloidal aluminum hydroxide, significantly reduces
struvite stone formation in rats. The prevention of severe renal infec-
tions is likely explained by a depressant effect on bacterial growth
exerted by low phosphaturia, an effect confirmed in our preliminary "in
vitro" experiments.
B and T cell function in patients with primary IgA glomerulonephritis.
L. Cagnoli, E. Beltrandi, S. Pasquali, L. Rossi, R. Biagi, and P.
Zucche/li. Divisione di Nefrologia e Dialisi e Servizio di Laboratorio,
Ospedale M. Malpighi, Bologna, Italy. Recent reports have described
the presence of numerical and functional abnormalities of lymphocyte
subpopulations and subsets in primary IgA glomerulonephritis (IgA
GN). The authors studied the distribution of peripheral T lymphocyte
subsets and the "in vitro" function of B and T lymphocytes in 16
patients with biopsy proven IgA nephropathy without signs or symp-
toms of systemic disease. T cell subsets were identified by using
monoclonal antibodies directed at human T lymphocyte subsets termed
OKT3, OKT4, and OKT8 in an indirect immunofluorescence assay
taken in all patients. Twenty-three healthy age and sex-matched volun-
teers were used as controls. B cell function was examined in an "in
vitro" assay of IgG and IgA production by the use of PWM in cultures
containing mixtures of B cells from patients (Bp) or from normal
subjects (Bn) with T cells from normal donors treated with mitomycin C
(Tnx). To evaluate whether some functional T cell abnormalities existed
in patients with IgA GN, Bn were stimulated "in vitro" with PWM in
the presence of Tnx and T cells from patients with IgA GN (Tp). IgG
and IgA levels were measured in the supernatant and compared with the
amount of the same immunoglobulins produced by cocultures of Bn,
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PWM, Tnx, and T cells from normal subjects (Tn). No significant
differences were found between the normal group and that of patients
with IgA GN either in the total number of lymphocytes or in the
OKT3+, OKT4+, OKT8+ cell percentage, or in the average of
OKT4+/OKT8+ ratio. B lymphocytes from patients with IgA GN
produced significantly more IgA that B lymphocytes from controls
when they were stimulated "in vitro" by PWM and Tnx (274.6 38 vs.
157.6 30.2 SEM nglml, Student's t test P < 0.05). No difference was
seen in the IgG synthesis between patients and the control group. T
lymphocytes from patients with IgA GN were more efficient than T
cells from controls in providing specific IgA helper activity for normal B
cells (348.7 45.3 vs. 115 25.3 SEM nglml, Student's t test P <0.005).
The amount of IgG produced in the supernatant of the cocultures was
similar both when Tp cells or Tn cells were added to the Bn, PWM, and
Tnx system. In conclusion, a hyperfunction of B cells specifically
directed to IgA production and a helper activity of T cells on IgA
synthesis seem to coexist in patients with IgA GN, without numerical
abnormalities of T cell subsets. Which of the two defects is more
important and primary and what might be the correlation between the
two in vivo are yet to be demonstrated.
Immune complexes containing IgAl and IgA2 in alcoholic liver cirrho-
sis. R. Coppo, B. Basolo, M. R. Buizomi, F. Giacchino, A. Sessa, A.
Volpi, F. Bonino, S. Aricd, C. Guarena, N. De Marco, and G. Piccoli.
Chair of Medical Nephrology of the University of Torin, Gastroenterol-
ogy Department, S. Giovanni Hospital, and Gastroenterology Depart-
ment, Mauriziano Hospital, Torin, and Nephrology and Dialysis Unit,
Vimercate Hospital, Milan, Italy. Since mucosal IgA are almost equally
constituted by dymeric IgAl and IgA2, whereas serum IgA, mainly
monomeric are represented by 90% of IgA I, the study of IgA subclasses
in IgA containing circulating immune complexes (IgAIC) and of serum
polymeric IgA (pIgA) can be useful for investigating the origin of IgAIC
in diseases. To study the presence and the origin of lgAlC in patients
with alcoholic liver cirrhosis (ALC), the authors examined 11 patients
with ALC and IgA glomerular deposits (group A) and 21 patients with
ALC without proteinuria or microscopic hematuria (group B) by
analyzing: (1) lgAIC (conglutinin solid phase assay); (2) IgAIIC and
IgA2IC (amplified conglutinin solid phase assay); (3) polymeric IgA
(reduction-alkilation test). Significantly high levels of IgAIC constituted
by both subclasses, and polymeric IgA were detected (see table)
independently from the presence or the activity of clinically manifest
renal involvement.
IgAIC IgAlIC IgA2IC
ig aggr. IgA/ml
Controls
Group A
Group B
25.8 65
498.1 413"
670.2 740"
15.4 52
617.8 744a
595.1 710"
17.3 49
1414.2 776'
956.3 998"
P < 0.001 than controls.
No significant correlation was observed between IgAIC, IgAlIC,
IgA2IC, or polymeric IgA and bile acid or bilirubin levels, while a
significant correlation was found between IgA2IC levels and alkaline
phosphatase (r = 0.75; P < 0.01) or yGT (r = 0.61; P <0.05) in patients
of group A and between total IgAIC and SGOT (r = 0.43; P <0.02) or
SGPT (r = 0.46; P < 0.02) in both groups. The data obtained agree with
the hypothesis of impaired liver clearance of IgAIC continuously
produced by altered intestinal mucosa surface, or of increased synthesis
of IgA possibly in portal spaces, due to alimentary antigen challenge in
cirrhotic patients.
Clinical features of autoimmunity and association with symptomless
autoimmune thyroiditis in primary renal glycosuria. S. Dc Marchi, E.
Cecchin, G. Proto, A. Basile, W. Donadon, D. Schinella, A. lengo, P.
Dc Paoli, A. Jus, D. Villalta, G. Santini, and F. Tesio. Department of
Internal Medicine, Stabilimento Ospedaliero Codroipo, Udine; Unit of
Nephrology and Dialysis, Cardiorheumatological Center; Department
of Immunology, Stabilimento Ospedaliero Pordenone, Pordenone,
Italy. The fortuitous discovery of significant titers of autoantibodies to
thyroglobulin (TgA) and thyroid microsomal (TMA) in a 27-year-old
woman affected with primary renal glycosuria (RG) prompted us to
evaluate several clinical and humoral features of autoimmunity in this
interesting "freak of nature." We studied five unrelated families
affected with RG for a total of 25 patients and 40 healthy relatives.
Control group consisted of 100 subjects with normal renal function. The
diagnosis of RG was determined by measuring fasting and daily
glycosuria and performing a renal glucose titration study. Other inherit-
ed and acquired renal tubule dysfunctions were excluded. We investi-
gated a large variety of autoantibodies including antibodies to nuclear
antigens (ANA), native DNA (nDNA), smooth muscle (SMA), mito-
chondria, gastric parietal cells, pancreatic islets, liver antigens (ALA),
TgA, and TMA. All the affected family members had significant titers of
ANA, nDNA, SMA, ALA, TgA, TMA, and mitochondria in variable
association, but there were no overt symptoms of autoimmune disease.
On the other hand, none of the unaffected family members had
significant autoantibodies titers. Four affected members, presenting
high titers of TgA and TMA, were submitted to the evaluation of serum
concentrations of T3, T4, basal TSH, and TSH response to TRH
administration (200 sg iv.). In these patients T3, T4, and basal TSH
values were in the normal range, but everyone had an exaggerated TSH
response to TRH, an expression of an increased hypophysis reserve of
TSH and index of primary subclinical hypothyroidism. The association
of circulating thyroid antibodies with a low thyroid reserve provides
evidence for a symptomless autoimniune thyroiditis. Most of the
possible mechanism for the association of RG and symptomless autoiin-
mune thyroiditis as well as the causes of such susceptibility to multiple
autoantibodies production in RG remain matter for future research.
E Hypts Renal volume response to0 Right k,d,,ey
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study. G. Curatola, C.
Zoccali, and Q. Maggiore.
Centro di Fisiologia Clin-
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Fur in 12 essential (F) hypertensive patients (Hypts) and in 24 Hypts
with unilaterally reduced renal mass due to either renal artery stenosis
(RAS, N = 15) or pyelonephritis/hypoplasia (PH, N = 9). Comparable
changes occurred on both kidneys of E Hypts (top panel of figure).
Responses of RAS (middle panel) and PH (bottom panel) kidneys
showed diverging trends (RAS blunted, PH exaggerated) such as the
difference in peak response between the normal and the small sized
kidney of each pair yielded positive values in 14 of 15 RAS Hypts and
negative values in 8 of 9 PH Hypts. The data suggest that the blunted
response to Fur of a small kidney is indicative of arterial stenosis.
Natural history of IgA mesangial deposits glomerulonephritis (IgA-
GN). Clinical outcome in 56 patients with a postrenal biopsy follow-up
over then 10 years. G. B. Fogazzi, E. Imbasciati, E. Mariani, F.
Ferrario, A. Castiglione, A. Ragni, G. Barbiano di Belgioioso, L.
Redaelli, and S. Bertoli. Divisioni di Nefrobogia di:Ospedale Maggiore,
S. Carlo, Cd Granda, Milano, Italy. IgA-GN is generally thought to run
a slow and prolonged course. An adequate period of observation is
mandatory to evaluate correctly the natural history of the disease. The
clinical outcome of 56 patients, 37 males and 19 females with a mean age
of 32.2 (10 to 61) years, with IgA-GN diagnosed by renal biopsy (RB)
between 1968 and 1972, and followed for at least 10 years is reported. At
the end of follow-up (114.8 16.0 months) 9 patients (16.0%) had
achieved complete remission (normal serum creatinine and normal
urinalysis) (group 1); 25 patients (44.6%) still had persistent abnormal
—a
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urinalysis with normal renal function (group 2); 10 patients were
progressed to chronic renal insufficiency (mean plasma creatinine 2.6
1.0 mg/dl) (group 3); 12 patients (21.4%) were on regular dialysis (group
4). The prevalence of the following parameters, when evaluated at
moment of RB, was significantly higher in groups 3 and 4 at the end of
follow-up than in patients of groups I and 2: proteinuria  2.0 g/24 hr
(5.8 vs. 22.7%, P < 0.05); plasma creatinine  1.5 mg/dl (5.8% vs.
31.8%, P < 0.005); segmental glomerular sclerosis 30% (6.2 vs.
40.0%, P < 0.005); severe interstitial fibrosis (2+/3+) (12.5 vs. 55.0%, P
<0.025). On the contrary episodes of macrohematuria were significant-
ly more frequent in groups I and 2 (55.8% vs. 9.0%, P < 0.005). Sex,
age, interval between the onset of the disease and the RB, IgA serum
levels, mesangial and extracapillary proliferation, vascular lesions were
equally distributed among the four groups. In conclusion, the follow-up
over 10 years of IgA-GN shows that about 40% of patients can progress
to renal insufficiency, while some 16% of patients can achieve a
complete and prolonged remission of renal symptoms. Proteinuria  2.0
g124 hr, plasma creatinine  1.5 mg/dl, hypertension, severe glomerular
hyalinosis and sclerosis, and severe interstitial fibrosis, can be consid-
ered as markers of bad prognosis, while, in our experience, episodes of
gross hematuria are generally accompanied by a long-term fair
prognosis.
Role of dopaminergic receptors in the regulation of renin-angiotensin-
aldosterone system. N. Frisina and M. Buemi. Istituto Medicina In-
terna, Universitd Messina, Messina, Italy. The purpose of this research
is to verify by which type of dopaminergic receptor (D1 or
aldosterone secretion is modulated. Researches have been carried out
on 24 healthy volunteers, divided into four groups, four male and two
female subjects each. ACTH Beta 1-24 (0.5 mg i.v.) was administered to
all four groups. The second and third groups were given L-Dopa (500
mg) plus Benserazide (central decarboxylating enzyme inhibitor) orally
1 hr before ACTH administration; the third and fourth groups were
given Domperidone (10 mg i.v.) I mm before ACTH. In all subjects
blood samples were performed at 0, 30, 60, 90, and 120 mm. In blood
samples PRA, cortisol aldosterone were dosed. Blood pressure and
heart rate were monitored in these studies. L-Dopa plus benserazide
caused a statistically significant reduction of blood aldosterone re-
sponse to ACTH load versus control at 30 mm (from 14.2 1.4 to 9.2
0.8 zg/ml), but it did not modify plasma cortisol response. The basal
PRA of the second group, if compared with the first group, would
increase from 1.2 0.4 to 1.8 0.6 zg/ml/hr, (P < 0.5), but not the
cortisol one because of ACTH. Domperidone would neither modify
aldosterone activity due to ACTH nor remove L-Dopa inhibition upon
aldosterongenetic effects of ACTH. L-Dopa, which is transformed into
dopammne only at the periphery, due to its association with Bensera-
zide, inhibits the secretion of Aldosterone. Such pharmacological
inhibition is not removed by the block of the D2 receptors, effected by
Domperidone. So we sustain that D1 receptors are to be considered the
mediator for L-Dopa effects, through its transformation into doparnine.
Since significative PRA variations were absent, we suppose the dopa-
minergic stimulation does not effect the secretion of renin.
Analysis of the body phosphorous (P) in the uremic patients. F.
Mastrangelo, S. Rizzelli, C. Corlianà, L. Alfonso, V. De Blasi, M.
Aprile, A. M. Montinaro, M. Napoli, and G. Campana. Department of
Nephrology and Dialysis, "V. Fazzi" Hospital, Lecce, Italy. It has
been supposed that an increased extrarenal clearance of P, affected by
the circulating levels, occurs in uremic patients. We evaluated this
phenomenon and the effects of depurative therapy. A venous infusion
of standard P solution has been given to 30 uremic patients (residual
diuresis: < 200 mI/day). The patients were submitted to different
depurative therapies (acetate or bicarbonate dialysis, hemofiltration) at
the end of the infusion. The phosphate distribution spaces (total and
intracellular space), the extrarenal clearance of the phosphate, the body
pool, the turnover time, and the cellular uptake of phosphate have been
examined. A contemporaneous study of the acid-base balance and the
circulating PTH levels has been performed. The total P space turned out
to be increased (increase of the 40%), whereas the increase of the
cellular space was much higher (300%). The curve of increase of the
serum P levels was less steep compared to the theoretical curve
foreseen for the anuric patients: In confirmation of these data, the
cellular P clearance increased. A direct correlation between the in-
crease of the P space and the circulating PTH levels is not proven. The
parathyroidectomy performed in two patients caused an expansion of
the spaces. On the contrary, a relation of the space levels and the
extrarenal clearance with the blood pH values and the serum bicarbon-
ates took place. In confirmation of these data, the bicarbonate dialysis
(which allows a better correction of the metabolic acidosis) causes
lower values of the P pool (t = 2.97), total space (t = 3.67), cellular
space (t = 3.75), and cellular P clearance (t = 4.01). A better depuration
of the P is demonstrated during bicarbonate dialysis as due to the
absence of the acetate metabolism. The data confirm the hypothesis
that the P distribution spaces in the uremic patients are dependent on
other factors besides PTH: Among these, the uremic acidosis and the
chronic load of P are factors of primary importance.
Furosemide-sensitive sodium efflux in lymphocytes from normotensive
and hypertensive subjects. A. Novarini, A. Montanan, E. Sani, P.
Schianchi, I. Simoni, and A. Borghetti. Istituto di Semeiotica Medica,
Parma, Italy. The effect of furosemide on the ouabain-resistant rate
constant of sodium effiux (°KNa) from lymphocytes into a sodium-free
medium was measured in 17 normotensive control subjects (NC) and 13
essential hypertensive patients (EHP). Isolation of lymphocytes from
the blood, washing, 22Na loading procedure, and effiux measurement
were made in a sodium free, MgCl2, sucrose solution. The °KNa was
measured as the rate of appearance of 22Na into the external medium
within 400 sec after the starting of effiux at 37°C. Under these
conditions, lymphocytes sodium content was 3.5 0.5 SEM in EHP and
3.4 0.5 mrvi lO_12 cells in NC. The ouabain-resistant, unidirectional
°KNa was 154 15 sec6 in EHP and 184 16 in NC, while in the
presence of both ouabain plus furosemide it was 132 16 in EHP and
109 15 sec6 in NC. The furosemide sensitive, ouabain resistant
°KNa was 25 7 sec6 in EHP and 75 5 sec6 in NC (P < 0.001). In
human lymphocytes there is an ouabain resistant, furosemide-sensitive
fraction of Na efflux into a Na-free medium; this fraction may be
reasonably attributed to a Na-K cotransport system, as demonstrat-
ed in a similar way in other human and animal cells. This sodium
transport pathway seems to be reduced in lymphocytes from essential
hypertensive patients.
Decreased capacity of serum to solubilize circulating immune complex-
es (CIC) in patients with chronic glomerulonephritis (GN). A. Past ore, B.
Varvara, and F. P. Schena. C/mica Medica II, University of Ban, Ban,
Italy. The removal of soluble CIC is a function of various factors
including the capacity of serum to solubilize CIC. The solubilization
phenomenon determines tremendous structural alterations consisting of
a markedly reduced molecular weight and an altered antigen/antibody
ratio. Solubilization is a complement function mediated by the alterna-
tive pathway and enhanced by the classical pathway. In 33 patients with
chronic GN and in 15 patients with SLE (seven patients with active
disease and eight with inactive disease), the complement-mediated
solubilization (CMS) was investigated in vitro' incubating the patient's
serum with preformed radiolabelled IC (25I-BSA-rabbit anti-BSA) in
different proportions of antigen (Ag) and antibody (Ab). CMS was
compared with serum levels of C4, C3, fB, BIH, and C3bINA. Results
showed low CMS in presence of IC in slight Ag excess in 76% of
patients with chronic GN and high or low significant values of C3bINA
and BIH (P < 0.05). In patients with active SLE, CMS reduced in the
presence of IC in slight Ab excess in 71% of the patients and in the
presence of IC in slight Ag excess in 85% of the patients. The values
improved in 40% of inactive SLE. C4 and C3 increased, whereas BIH
and C3bINA remained in the normal range. These data suggest that low
CMS in the presence of IC in slight Ag excess in patients with chronic
GN is due to altered serum levels of BIH and C3bINA which could
inhibit the function of C3bBb convertase and cause a relative C3b
deficiency. In active SLE and low CMS could be related to the
increased consumption of complement.
Epidemiology of hypertension in children. A. Papa, A. Dal Canton, A.
Capuano, G. Conte, F. D'Anna, L. D'Avanzo, N. Lavecchia, and V. E.
Andreucci. Department of Nephrology, Second Faculty of Medicine,
University of Naples, Naples, Italy. Seven thousand and eight students,
aged 10 to 15 years, were examined in their schools by the authors.
Systolic and diastolic blood pressure (SBP and DBP, respectively),
heart rate (HR), the height and body weight were recorded. In the
whole population, both SBP and DBP rose linearly with age; the mean
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increment per year was 2.5 and 1.1 mm Hg, respectively. When the
mean + I SD for the corresponding age and sex subgroup was taken as
the upper limit of "normal" blood pressure, 27.3% had "elevated" SBP
and/or DBP. Children with "elevated" blood pressure had a greater
body weight (P < 0.0001) and ponderal index (P < 0.001), and a higher
HR (P < 0.001) than "normal" children. A representative group of
"normal" children (N = 60) and children with "elevated" blood
pressure (N = 72) was randomly selected from the whole population
and examined again after 1 and 2 years. In 63% of children with
"elevated" blood pressure lat the first control, SBP and/or DBP were
"normal" in at least one of the successive examinations. In the
remaining 37%, SBP and DBP were steadily greater than the mean + 2
SD. In conclusion, this study defined the mean values of SBP and DBP
in a large children population. In this population, excessive body weight
and higher HR were associated with greater values of blood pressure. A
blood pressure exceeding the mean + 2 SD may be a correct criterion to
select those children that are in risk for future essential hypertension.
Who needs high sodium dialysate (HNaD)? L. Pedrini, R. Ponti, R.
Costanzo, S. Di Filippo, P. Marai, C. Pozzi, C. Dell'Oro, and F.
Locatelli. Divisione di Nefrologia e Dialisi, Ospedale di Lecco, Lecco,
Italy. The aim of this study is to evaluate the long-term results of HNaD
and establish its clinical application. One hundred sixty-eight patients,
mean age 48.4 13.9 years, were observed for a mean of 41.6 21.6
months of HD (4 hr thrice weekly) using a NaD ranging between 142
and 155 mEq/liter. Eighty-seven percent of the patients were hyperten-
sive at the beginning of the study, 62.5% after 6 months, and 44.6% at
the end. Mean blood pressure (BP) values were 176.9/102.3 mm Hg at
the beginning and 153.2/90.1 mm Hg at the end (P < 0.001). Thirty out
of 168 patients were observed for a mean of 82.3 15 months, using
NaD of 142 mEq/liter (29.3 15 months) and then of 148 mEq/liter (53
months). BP decreased significantly (P < 0.001) from 166.7/100.4 mm
Hg (basal values) to 145.5/88.2 mm Hg with NaD 142 and 142/86.2 with
NaD 148. The percentage of hypertensive patients decreased from 73.3
to 30% with NaD 142 and to 23.3% with NaD 148 mEq/liter. Intradialy-
tic vascular stability, evaluated by recording the amount of osmotically
active substances infused during HD to treat hypotension, improved
statistically with the progressive increase of NaD; however, interdialy-
tic weight gain also increased statistically. No patient suffered from
symptomatic interdialytic hypotension. HNaD, avoiding sodium deple-
tion, which is known to impair the sympathetic response, hampers the
progressive unphysiological reduction of blood pressure in long-term
hemodialytic treatment. The advantage of this effect is questionable in
hypertensive patients, mainly with high interdialytic weight gain. On
the other hand, HNaD, preventing the intradialytic vascular instability
and the interdialytic chronic hypotension, is certainly useful for norma-
tensive and hypotensive patients.
Significance of fibronectin in human glomerulonephritis (GN). G.
Pertosa, C. Grasso, C. Germinario, and F. P. Schena. Clinica Medica
II, University of Bar Ban, Italy. Fibronectin (FN) is a polymorphic
glycoprotein found in plasma and on the surface of cells. Its activity
includes the ability to mediate cell adhesion and promote the attach-
ment of certain bacteria and immune complexes to macrophages.
Plasma FN was determined in 35 patients with idiopathic or secondary
GN, 15 undergoing recurrent hemodialysis, and 7 renal transplanted
patients. Its distribution in the human kidney was evaluated by indirect
immunofluorescence of 21 renal biopsy specimens presenting various
types of UN. The mean value of FN in idiopathic GN did not differ from
that in normal control subjects, whereas significantly low mean values
were found in secondary GN (P < 0.005), in patients before and after
dialysis (P < 0.025), and in renal transplants (P < 0.025). FN levels
were greatly decreased in those patients who presented severe infection
or sepsis and in acute renal rejection in which increased serum
creatinine correlated significantly with low levels of FN (r =
—0.6126, P
< 0.01). Increased deposits of FN were found in GN characterized by
mesangial proliferation (Berger disease and membranoproliferative
GN). These data suggest that low levels of plasma FN in patients with
secondary GN may be related to enhanced opsonic function of this
protein. The increased amount of FN deposits in the glomerular
structure may favor the clearance of the tissue debris and immune
complex deposits. The low values of FN in patients with chronic
hemodialysis suggest that the kidney may play a role in the physiologic
regulation of plasma FN. In fact, acute renal damage occurring in acute
rejection determines a rapid decrease of the plasma levels of FN. In this
way they could be most useful to diagnose renal rejection.
Interaction between macrophage system and IgA immune complexes in
IgA nephropathy. D. Roccatello, R. Coppo, G. Martina, C. Rollino, B.
Basolo, G. Picciotto, P. G. Defihippi, F. Bayle, D. Cordonnier, and G.
Piccoli. Chair of Medical Nephrology of the University of Torino,
Nephrology and Dialysis Units, S. Giovanni Hospital, and Nuclear
Medicine Department, S. Giovanni Hospital, Torin, Italy, and Centre
Hospitalier Universitaire, Grenoble, France. It has been suggested that
IgA containing immune complexes (IgAIC) are involved in the patho-
genesis of IgA nephropathy. On the other hand, the macrophage system
is thought to have a critical role in the removal of IC. To evaluate the
possible interaction between IgAIC and macrophage system, eight
patients with primary IgA nephropathy (pIgAGN), three patients with
Henoch-SchOnlein nephritis (HSGN), and three patients with alcoholic
cirrhosis associated glomerulonephritis (ACGN) were studied by mea-
suring: (1) clearance of anti-D coated 5Cr-labelled red blood cells
(RBC), (2) IgAIC and IgGIC (conglutinin solid phase assay), (3) C3d,
and (4) fibronectin. The half-life of sensitized RBC (T50) was 30.1 6.4
mm in ten control subjects, 52.6 27.5 mm in pIgAGN (P < 0.02), 45.3
19 mm in HSGN, 60.3 27.9 mm in ACUN. A strict correlation was
found between T50 values and levels of IgAIC (r = 0.5, P < 0.05) or (in
pIgAGN) of C3d levels (r = 0.9, P <0.01). Three of eight patients with
pIgAGN and two of three ACGN had an abnormal RBC clearance.
They also had high levels of IgAIC, C3d (three of three, pIgAGN), and
(two patients with pIgAGN) signs of abnormal metabolism of fibronec-
tin. They presented major signs of clinical activity and a very unfavor-
able course. Our data suggest that in patients with IgA nephropathy a
defective macrophage receptor function might lead to persistently high
levels of circulating IgAIC, thus influencing the course of the disease.
Immune complexes solubilizing capacity in immunologically mediated
glomerular diseases. Effect of plasma exchange. R. Sinico, G. Balestrieri,
A. Fornasieri, A. Tincani, P. Nista, P. Bernasconi, R. Cattaneo, and
G. D'Amico. Department of Nephrology, Ospedale San Carlo Borro-
meo, Milan, and Service of Immunology, Spedali Civihi, Brescia, Italy.
Normal human serum has the property to solubilize immune complexes
(IC) preformed "in vitro" and inhibit their precipitation. These comple-
ment-mediated functions are particularly depressed in diseases charac-
terized by circulating IC and/or hypocomplementemia. Plasma ex-
change (PE) could theoretically influence these functions, both by
removing complement consuming IC and supplying complement factors
with the reinfused plasma. Therefore, in addition to standard immuno-
logical parameters (serum IC, DNA-binding, complement factors C3,
C4, Clq, C3d, CH5O, and alternative pathway activity), we carried out
a serial evaluation of IC solubilizing capacity (ICSC) and of the IC
precipitation inhibition capacity (ICPIC) in 21 patients affected by
severe forms of glomerulonephritis (GN) treated with intensive PE (for
a mean of 15 procedures) plus corticosteroids (and/or immunosuppres-
sive drugs). Each time 70% of the patient's plasma volume was
exchanged for fresh frozen plasma or albumin (two patients). Group 1:
Ten patients presented lupus nephritis with histological evidence of
diffuse proliferative GN in eight and membranous GN in two; six
patients presented a rapid decline in renal function and nine patients
had extrarenal symptoms. Group 2: Five patients presented essential
mixed IgG-IgMK cryoglobulinemia with histological evidence of prolif-
erative GN. Two patients also showed endoluminal thrombi and one
patient necrotizing vasculitis. Group 3: Six patients presented systemic
necrotizing vasculitis with various types of histological lesions. Three
patients suffered "classical" polyarteritis nodosa, one had Wegener
granulomatosis, one Henoch-Schönlein purpura, and the last one a
systemic necrotizing angiitis associated with IgGK cryoglobulinemia.
In group I ICSC was initially depressed in all patients (25 27.6%; n.y.
85%) while ICPIC was depressed in eight often patients (76.4 19.6%;
n.y. 90%); both these values returned to normal in all patients but the
one who failed to respond to treatment and required chronic hemodialy-
sis. In group 2 basal values for ICSC and ICPIC were depressed in all
patients (ICSC = 36.1 34.2%; ICPIC = 65.5 34.6%) and remained
nearly unchanged after the treatment, with no correlation with the
clinical outcome. In group 3 ICSC was depressed in five of six patients
(60.5 28.1%) whereas ICPIC was always normal in all patients (93.3
3.3%). After the treatment ICSC increased or returned to normal only in
the four patients which showed clinical improvement. In conclusion,
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ICSC and ICPIC seem to be of greater value in the clinical monitoring of
patients with severe GN associated with severe systemic diseases. The
role of PE and immunosuppressive drugs in restoring these functions
needs further clarification.
Dopaminergic control of prolactin, sympathetic tone, and blood pres-
sure in hemodialysis patients. A. Sturani, C. Chiarini, E. Degli Esposti,
A. De March, G. Fuschini, A. Santoro, A. Zuccalà, C. Flamigni, and
P. Zucchelli. Divisione di Nefrologia e Dialisi, Ospedale M. Malpighi e
Fisiopathologia della Riproduzione, Ospedale S. Orsola, Bologna,
Italy. Bromocriptine was used to test the hypothesis that the abnormali-
ty of the dopaminergic system described in hemodialysis patients may
cause enhanced sympathetic activity and high blood pressure. Hormon-
al and blood pressure responses to tilt and cold pressor tests were
examined in six hypertensive hemodialysis patients after a week of
treatment with bromocriptine (2.5 mg/day). The data were compared to
those obtained during the placebo period. All hemodialysis patients
were hyperprolactinemic. Six normal age sex-matched subjects were
also studied as controls. Bromocriptine significantly reduced supine
mean blood pressure (119 4.7 vs. 106 4.9 mm Hg, P < 0.01) and
plasma noradrenaline (278 88 vs. 173 45 ng/liter, P < 0.05).
However, the associated reduction in heart rate was not significant. A
significant relationship was observed between the pretreatment nor-
adrenaline plasma levels and the changes in mean supine blood pressure
induced by bromocriptine (r = 0.758, P < 0.05). Although the incre-
ments in plasma noradrenaline during the tilt test were reduced by
bromocriptine, there was a significant improvement in the response of
mean blood pressure (—4.8 1.1 vs. 2.8 1.7mm Hg, P <0.05). Our
data support the hypothesis that a defective dopaminergic control is the
common cause of high plasma prolactin levels and increased sympathet-
ic tone in some hemodialysis patients, and that it is a factor in the
maintenance of elevated blood pressure levels. Normalization of central
dopaminergic activity by bromocriptine therapy leads to the restoration
of plasma prolactin and sympathetic tone and blood pressure to normal
levels. Moreover, it re-establishes a normal relationship between nor-
adrenaline and adrenergic receptors.
Hemodynamic and mechanisms of hypertension in polycystic kidney
disease (PKD). E. Valvo, L. Gammaro, G. Panzetta, A. Lupo, C.
Loschiavo, N. Tessitore, L. Oldrizzi, A. Fabris, C. Rugiu, V. Orialda,
and G. Maschio. Divisione Clinicizzata di Nefro/ogia, Universitd di
Verona, Verona, Italy. Hypertension occurs in 50 to 80% of patients
with adult PKD. Little information is available on the pathogenesis and
the hernodynamic changes of this hypertension. Thirty-two PKD pa-
tients, 16 with normal, 16 with variably decreased renal function, were
studied; 12 had normal (NBP), 20 high blood pressure (HBP). They
were hospitalized and placed on a diet containing 100 mEq Nat Supine
and standing PRA, GFR, and plasma volume (PV) were evaluated.
Mean arterial pressure (MAP), heart rate (HR), and cardiac output (CO)
were measured and total peripheral resistance (TPR) was calculated.
MAP was 90 8 mm Hg in NBP and 117 17 in HBP patients; PRA
was 0.75 0.69 ng/ml/hr in supine and 2.19 1.83 in the standing
position in NBP patients; 0.73 0.43 (NS), and 1.80 1.20 (NS),
respectively, in HBP patients. GFR was lower, statistically not signifi-
cant, in HBP than in NBP patients: 67 46 and 91 49 mI/mm,
respctively; no correlation was found between MAP, and PRA or
GFR. PV was higher in HBP than in NBP patients: 46 4 ml/kg body
weight and 40 4, respectively (P < 0.01): it correlated with MAP (r =
0.465, P < 0.01), and did not with GFR. Cardiac index was 3.48 0.71
liter/mm/rn2 in NBP and 3.89 1.47 in HBP patients (P < 0.01); HR 66
10 b/mm and 71 10 (NS) respectively; TPR index 2035 503 dynes/
secIcm5/m2 in NBP and 2507 808 in HBP patients (P < 0.05). No
correlation was found between MAP and CO. TPR and PRA; a
significant positive relationship was seen between CO and PV (r =
0.613, P < 0.001) and between MAP and TPR (r = 0.420, P < 0.05).
PRA was similar in NBP and HBP patients: Furthermore, PV did not
correlate with PRA and TPR. Then PRA is inappropriately high for a
volume-expanded population, and PV is inappropriately high for the
decreased capacity of the circulation. In conclusion, our findings
indicate that arterial hypertension is primarily volume-dependent in
patients with PKD; the increase in PV is not a consequence of the loss
of the renal excretory function; vasoactive factors, included RAS, may
play a role in maintaining the hypertensive state. Hemodynamically,
hypertension is characterized by high CO and TPR.
